REGENXBIO (RGNX) News Today $8.68 -0.29 (-3.23%) Closing price 05/30/2025 04:00 PM EasternExtended Trading$8.92 +0.24 (+2.81%) As of 05/30/2025 07:48 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock RGNX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Two Sigma Advisers LP Acquires 112,000 Shares of REGENXBIO Inc. (NASDAQ:RGNX)Two Sigma Advisers LP grew its holdings in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 164.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 180,000 shares of the biotechnology company's stock afJune 1 at 3:59 AM | marketbeat.comTwo Sigma Investments LP Acquires 263,495 Shares of REGENXBIO Inc. (NASDAQ:RGNX)Two Sigma Investments LP increased its stake in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 209.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 389,428 shares of the biotechnology company's stock after buyinJune 1 at 3:58 AM | marketbeat.comFY2026 EPS Estimates for REGENXBIO Increased by AnalystREGENXBIO Inc. (NASDAQ:RGNX - Free Report) - Investment analysts at Leerink Partnrs lifted their FY2026 earnings estimates for shares of REGENXBIO in a note issued to investors on Tuesday, May 27th. Leerink Partnrs analyst M. Foroohar now forecasts that the biotechnology company will earn ($1.65)May 31 at 6:44 AM | marketbeat.comMillennium Management LLC Buys 1,061,187 Shares of REGENXBIO Inc. (NASDAQ:RGNX)Millennium Management LLC raised its stake in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 406.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 1,322,344 shares of the biotechnology company's stock aftMay 26, 2025 | marketbeat.comBNP Paribas Financial Markets Acquires 75,652 Shares of REGENXBIO Inc. (NASDAQ:RGNX)BNP Paribas Financial Markets boosted its holdings in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 370.1% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 96,093 shares of the biotechnology company's stock aftMay 25, 2025 | marketbeat.comQ2 Earnings Forecast for REGENXBIO Issued By Leerink PartnrsREGENXBIO Inc. (NASDAQ:RGNX - Free Report) - Equities research analysts at Leerink Partnrs increased their Q2 2025 EPS estimates for shares of REGENXBIO in a report issued on Monday, May 19th. Leerink Partnrs analyst M. Foroohar now forecasts that the biotechnology company will post earnings of (May 24, 2025 | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) Shares Purchased by Jane Street Group LLCJane Street Group LLC lifted its stake in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 325.3% during the 4th quarter, according to the company in its most recent filing with the SEC. The fund owned 164,911 shares of the biotechnology company's stock after acquiring an additional 126,135 shares durMay 23, 2025 | marketbeat.comRegenxbio at RBC Conference: Strategic Moves and Clinical ProgressMay 22, 2025 | investing.comREGENXBIO FY2025 EPS Forecast Reduced by Chardan CapitalREGENXBIO Inc. (NASDAQ:RGNX - Free Report) - Investment analysts at Chardan Capital reduced their FY2025 EPS estimates for REGENXBIO in a research report issued to clients and investors on Wednesday, May 14th. Chardan Capital analyst D. Gataulin now anticipates that the biotechnology company willMay 21, 2025 | marketbeat.comREGENXBIO Inc.: REGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 MillionMay 20, 2025 | finanznachrichten.deREGENXBIO announces royalty monetization agreement for up to $250MMay 20, 2025 | msn.comREGENXBIO Announces Strategic Royalty Monetization Agreement for Up to $250 MillionMay 19, 2025 | prnewswire.comPoint72 Asia Singapore Pte. Ltd. Makes New $447,000 Investment in REGENXBIO Inc. (NASDAQ:RGNX)Point72 Asia Singapore Pte. Ltd. purchased a new position in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 57,841 shares of the biotechnology company's stMay 18, 2025 | marketbeat.comHudson Bay Capital Management LP Has $2.38 Million Position in REGENXBIO Inc. (NASDAQ:RGNX)Hudson Bay Capital Management LP boosted its holdings in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 43.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 308,100 shares of the biotechnology compaMay 16, 2025 | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) Director Sells $162,961.82 in StockMay 15, 2025 | insidertrades.comEarnings Miss: REGENXBIO Inc. Missed EPS By 64% And Analysts Are Revising Their ForecastsMay 15, 2025 | finance.yahoo.comFDA Accepts Biologics License Application for Mucopolysaccharidosis II TreatmentMay 14, 2025 | prnewswire.comREGENXBIO Inc. (NASDAQ:RGNX) Shares Sold by Integral Health Asset Management LLCIntegral Health Asset Management LLC lowered its stake in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 29.4% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 900,000 shares of the biotechnology company's stock afMay 14, 2025 | marketbeat.comRegenxbio stock rises on FDA’s priority review for MPS II therapyMay 13, 2025 | investing.comREGENXBIO Announces FDA Acceptance and Priority Review of the BLA for RGX-121 for MPS IIMay 13, 2025 | prnewswire.comCubist Systematic Strategies LLC Makes New $2.79 Million Investment in REGENXBIO Inc. (NASDAQ:RGNX)Cubist Systematic Strategies LLC bought a new position in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) in the fourth quarter, according to its most recent disclosure with the SEC. The firm bought 361,313 shares of the biotechnology company's stock, valued at approximately $2,793,000. Cubist SystematiMay 13, 2025 | marketbeat.comBrevan Howard Capital Management LP Buys Shares of 41,160 REGENXBIO Inc. (NASDAQ:RGNX)Brevan Howard Capital Management LP purchased a new position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 41,160 shares of the biotechnoMay 13, 2025 | marketbeat.comREGENXBIO Inc.: REGENXBIO Reports First Quarter 2025 Financial Results and Recent Operational HighlightsMay 13, 2025 | finanznachrichten.deRegenxbio Inc (RGNX) Q1 2025 Earnings Call Highlights: Strategic Partnerships and Financial ...May 13, 2025 | finance.yahoo.comREGENXBIO Reports First Quarter 2025 Financial Results and Recent Operational HighlightsMay 12, 2025 | prnewswire.comBalyasny Asset Management L.P. Has $9.18 Million Stock Holdings in REGENXBIO Inc. (NASDAQ:RGNX)Balyasny Asset Management L.P. lifted its holdings in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 6.0% in the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,187,102 shares of the biotechnology company's stock after buying an addMay 12, 2025 | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) Given Average Rating of "Moderate Buy" by BrokeragesREGENXBIO Inc. (NASDAQ:RGNX - Get Free Report) has received an average rating of "Moderate Buy" from the six analysts that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold recommendation and five have issued a buy recommendation onMay 12, 2025 | marketbeat.comRaymond James Financial Inc. Takes Position in REGENXBIO Inc. (NASDAQ:RGNX)Raymond James Financial Inc. bought a new stake in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 73,510 shares of the biotechnology cMay 11, 2025 | marketbeat.comStifel Financial Corp Buys 39,564 Shares of REGENXBIO Inc. (NASDAQ:RGNX)Stifel Financial Corp raised its stake in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 26.5% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 188,844 shares of the biotechnology company's stockMay 10, 2025 | marketbeat.com5RGNX : What to Expect from Regenxbio's EarningsMay 9, 2025 | benzinga.comREGENXBIO (RGNX) Projected to Post Quarterly Earnings on WednesdayREGENXBIO (NASDAQ:RGNX) will be releasing its Q1 2025 earnings before the market opens on Wednesday, May 14. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2025-5-14-regenxbio-inc-stock/)May 9, 2025 | marketbeat.comREGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 28th Annual MeetingMay 8, 2025 | prnewswire.comHsbc Holdings PLC Acquires 48,310 Shares of REGENXBIO Inc. (NASDAQ:RGNX)Hsbc Holdings PLC grew its holdings in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 132.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 84,817 shares of the biotechnology company's stock after acquiMay 8, 2025 | marketbeat.comREGENXBIO to Participate in Upcoming Investor ConferencesMay 6, 2025 | prnewswire.comREGENXBIO Inc. (NASDAQ:RGNX) Shares Sold by Invesco Ltd.Invesco Ltd. reduced its position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 61.7% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 52,128 shares of the biotechnology company's sMay 6, 2025 | marketbeat.comPDT Partners LLC Makes New Investment in REGENXBIO Inc. (NASDAQ:RGNX)PDT Partners LLC purchased a new stake in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 63,015 shares of the biotechnology company's stock,May 4, 2025 | marketbeat.comREGENXBIO Inc. (NASDAQ:RGNX) Shares Sold by CANADA LIFE ASSURANCE CoCANADA LIFE ASSURANCE Co trimmed its stake in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 84.7% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,649 shares of the biotechnology company's stMay 3, 2025 | marketbeat.comLegal & General Group Plc Lowers Stock Holdings in REGENXBIO Inc. (NASDAQ:RGNX)Legal & General Group Plc lowered its stake in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 63.1% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 44,823 shares of the biotechnology company's sMay 3, 2025 | marketbeat.comAdage Capital Partners GP L.L.C. Buys Shares of 500,000 REGENXBIO Inc. (NASDAQ:RGNX)Adage Capital Partners GP L.L.C. bought a new position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 500,000 shares of the biotechnMay 2, 2025 | marketbeat.comREGENXBIO to Host Conference Call on May 12 to Discuss First Quarter 2025 Financial Results and Recent Operational HighlightsApril 30, 2025 | prnewswire.comRegenxbio Stock Short Interest Report | NASDAQ:RGNX | BenzingaApril 29, 2025 | benzinga.comRenaissance Technologies LLC Takes $2.10 Million Position in REGENXBIO Inc. (NASDAQ:RGNX)Renaissance Technologies LLC acquired a new position in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 271,300 shares of the biotechnology company's stock, valuedApril 28, 2025 | marketbeat.comQuantessence Capital LLC Takes $270,000 Position in REGENXBIO Inc. (NASDAQ:RGNX)Quantessence Capital LLC acquired a new position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) in the 4th quarter, according to its most recent 13F filing with the SEC. The fund acquired 34,888 shares of the biotechnology company's stock, valued at approximately $270,000. Quantessence CapApril 25, 2025 | marketbeat.com88,148 Shares in REGENXBIO Inc. (NASDAQ:RGNX) Bought by Walleye Capital LLCWalleye Capital LLC bought a new position in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm bought 88,148 shares of the biotechnology company's stock, valued at approximately $681April 25, 2025 | marketbeat.com332,814 Shares in REGENXBIO Inc. (NASDAQ:RGNX) Purchased by Voss Capital LPVoss Capital LP acquired a new position in REGENXBIO Inc. (NASDAQ:RGNX - Free Report) in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 332,814 shares of the biotechnology company's stock, valued at approximatApril 23, 2025 | marketbeat.comJump Financial LLC Grows Stock Holdings in REGENXBIO Inc. (NASDAQ:RGNX)Jump Financial LLC increased its holdings in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 144.9% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 192,708 shares of the biotechnology company'sApril 22, 2025 | marketbeat.comQ2 Earnings Estimate for REGENXBIO Issued By Leerink PartnrsREGENXBIO Inc. (NASDAQ:RGNX - Free Report) - Analysts at Leerink Partnrs issued their Q2 2025 earnings per share estimates for shares of REGENXBIO in a research report issued on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar forecasts that the biotechnology company will earn ($1.49) pApril 20, 2025 | marketbeat.comQ1 Earnings Estimate for REGENXBIO Issued By Leerink PartnrsREGENXBIO Inc. (NASDAQ:RGNX - Free Report) - Research analysts at Leerink Partnrs issued their Q1 2025 EPS estimates for shares of REGENXBIO in a research note issued on Wednesday, April 16th. Leerink Partnrs analyst M. Foroohar expects that the biotechnology company will post earnings of $0.65 pApril 19, 2025 | marketbeat.comXTX Topco Ltd Has $836,000 Stock Position in REGENXBIO Inc. (NASDAQ:RGNX)XTX Topco Ltd raised its holdings in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 720.5% during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 108,120 shares of the biotechnology company's stock afterApril 19, 2025 | marketbeat.comVanguard Group Inc. Sells 1,383,039 Shares of REGENXBIO Inc. (NASDAQ:RGNX)Vanguard Group Inc. lessened its holdings in shares of REGENXBIO Inc. (NASDAQ:RGNX - Free Report) by 31.7% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 2,985,952 shares of the biotechnology company's stock after selling 1,38April 17, 2025 | marketbeat.com Get REGENXBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address RGNX Media Mentions By Week RGNX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RGNX News Sentiment▼1.280.88▲Average Medical News Sentiment RGNX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RGNX Articles This Week▼95▲RGNX Articles Average Week Get REGENXBIO News Delivered to You Automatically Sign up to receive the latest news and ratings for RGNX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BLTE News CGON News NAMS News KYMR News GLPG News APGE News TARS News AGIO News CNTA News TWST News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RGNX) was last updated on 6/1/2025 by MarketBeat.com Staff From Our PartnersTrump Just Gave the Green Light to Rewrite Social Security?In a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredBanks aren’t ready for this altcoin—are you?I've never been more confident about a DeFi opportunity. This isn't about complex trading or risky bets. Th...Crypto 101 Media | SponsoredThe “supermetal” that could power AIWhile the headlines focus on AI models and chip speed, Elon Musk is investing in the material side of the stor...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe Buffett Indicator is screaming, “sell stocks, buy gold”A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredTrump Exec Order 14179 is wealth “gift” to good Americans?Is President Trump’s Executive Order 14179… A secret way to restore wealth for good citizens? If you’ve ...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding REGENXBIO Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share REGENXBIO With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
